In the research article “Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: A 3-year follow-up study” (2005) Dr. Bin Lu of the Department of Gastroenterology at Affiliated Hospital of Zhejiang Traditional Chinese Medicine College claims that H. pylori eradication can prevent gastric cancer by decreasing chronic gastritis, atrophy, and intestinal metaplasia. Dr. Lu’s supporting evidence was provided by a 3-year study in which 92 patients were given eradication therapy then displayed a decrease in Chronic gastritis, active gastritis, and atrophy, and 87 were left untreated then displayed an increase in intestinal metaplasia. The purpose of this research article was to show the impact of eradication therapies on improving gastric inflammation and preventing cancer. Dr. Lu establishes a scholarly and imploring relationship with other professionals in gastroenterology as well as healthcare professionals as a whole.
